206 related articles for article (PubMed ID: 9765509)
21. UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response.
Kruger EA; Blagosklonny MV; Dixon SC; Figg WD
Invasion Metastasis; 1998-1999; 18(4):209-18. PubMed ID: 10640907
[TBL] [Abstract][Full Text] [Related]
22. Staurosporine analogues - pharmacological toys or useful antitumour agents?
Gescher A
Crit Rev Oncol Hematol; 2000 May; 34(2):127-35. PubMed ID: 10799837
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of different subsets of immature thymocytes to apoptosis.
Chow SC; Snowden R; Orrenius S; Cohen GM
FEBS Lett; 1997 May; 408(2):141-6. PubMed ID: 9187355
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01.
Yeow WS; Ziauddin MF; Maxhimer JB; Shamimi-Noori S; Baras A; Chua A; Schrump DS; Nguyen DM
Br J Cancer; 2006 May; 94(10):1436-45. PubMed ID: 16705314
[TBL] [Abstract][Full Text] [Related]
25. Combinations of 5-fluorouracil with UCN-01 or staurosporine.
Sigmond J; Comijn EM; Kamphuis JA; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1503-6. PubMed ID: 15571286
[TBL] [Abstract][Full Text] [Related]
26. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
27. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
Toullec D; Pianetti P; Coste H; Bellevergue P; Grand-Perret T; Ajakane M; Baudet V; Boissin P; Boursier E; Loriolle F
J Biol Chem; 1991 Aug; 266(24):15771-81. PubMed ID: 1874734
[TBL] [Abstract][Full Text] [Related]
28. Differing effects of staurosporine and UCN-01 on RB protein phosphorylation and expression of lung cancer cell lines.
Shimizu E; Zhao MR; Nakanishi H; Yamamoto A; Yoshida S; Takada M; Ogura T; Sone S
Oncology; 1996; 53(6):494-504. PubMed ID: 8960146
[TBL] [Abstract][Full Text] [Related]
29. Reevaluation of the role of de novo protein synthesis in rat thymocyte apoptosis.
Chow SC; Peters I; Orrenius S
Exp Cell Res; 1995 Jan; 216(1):149-59. PubMed ID: 7813615
[TBL] [Abstract][Full Text] [Related]
30. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.
Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S
Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
Michie AM; Rena G; Harnett MM; Houslay MD
Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
[TBL] [Abstract][Full Text] [Related]
32. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis through the PKC pathway in cultured dermal papilla fibroblasts.
Ferraris C; Cooklis M; Polakowska RR; Haake AR
Exp Cell Res; 1997 Jul; 234(1):37-46. PubMed ID: 9223368
[TBL] [Abstract][Full Text] [Related]
34. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Hsueh CT; Kelsen D; Schwartz GK
Clin Cancer Res; 1998 Sep; 4(9):2201-6. PubMed ID: 9748140
[TBL] [Abstract][Full Text] [Related]
35. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.
Akinaga S; Nomura K; Gomi K; Okabe M
Cancer Chemother Pharmacol; 1994; 33(4):273-80. PubMed ID: 7506638
[TBL] [Abstract][Full Text] [Related]
36. PKC 412 sensitizes U1810 non-small cell lung cancer cells to DNA damage.
Hemström TH; Joseph B; Schulte G; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2005 Apr; 305(1):200-13. PubMed ID: 15777800
[TBL] [Abstract][Full Text] [Related]
37. Selective effects of the PKC inhibitors Ro 31-8220 and CGP 41,251 on PMN locomotion, cell polarity, and pinocytosis.
Keller HU; Niggli V
J Cell Physiol; 1994 Dec; 161(3):526-36. PubMed ID: 7962133
[TBL] [Abstract][Full Text] [Related]
38. Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC.
Mizuno K; Saido TC; Ohno S; Tamaoki T; Suzuki K
FEBS Lett; 1993 Sep; 330(2):114-6. PubMed ID: 8365480
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the efficacy of 7-hydroxystaurosporine (UCN-01) and other staurosporine analogs to abrogate cisplatin-induced cell cycle arrest in human breast cancer cell lines.
Lee SI; Brown MK; Eastman A
Biochem Pharmacol; 1999 Dec; 58(11):1713-21. PubMed ID: 10571245
[TBL] [Abstract][Full Text] [Related]
40. Activation of PKCalpha downstream from caspases during apoptosis induced by 7-hydroxystaurosporine or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL60 cells.
Shao RG; Cao CX; Pommier Y
J Biol Chem; 1997 Dec; 272(50):31321-5. PubMed ID: 9395460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
